Intrinsic Value of S&P & Nasdaq Contact Us

Sabra Health Care REIT, Inc. SBRA NASDAQ

NASDAQ Global Select • Real Estate • REIT - Healthcare Facilities • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$18.78
-7.7%
Analyst Price Target
$21.33
+4.9%

Sabra Health Care REIT, Inc. (SBRA) is a REIT - Healthcare Facilities company in the Real Estate sector, currently trading at $20.34. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of SBRA = $18.78 (-7.7% from the current price, the stock appears fairly valued). Analyst consensus target is SBRA = $21 (+4.9% upside).

Valuation: SBRA trades at a trailing Price-to-Earnings (P/E) of 32.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.7.

Financials: revenue is $775M, +7.5%/yr average growth. Net income is $156M, growing at +320.6%/yr. Net profit margin is 20.1% (strong). Gross margin is 65% (-9 pp trend).

Balance sheet: total debt is $2.6B against $2.8B equity (Debt-to-Equity (D/E) ratio 0.9, moderate). Current ratio is 0.56 (tight liquidity). Debt-to-assets is 46.4%. Total assets: $5.5B.

Analyst outlook: 11 / 29 analysts rate SBRA as buy (38%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 41/100 (Partial), Growth 83/100 (Pass), Past 75/100 (Partial), Health 17/100 (Fail), Moat 55/100 (Partial), Future 34/100 (Fail), Income 85/100 (Pass).

$21.33
▲ 4.87% Upside
Average Price Target
Based on 29 Wall Street analysts offering 12-month price targets for Sabra Health Care REIT, Inc., the average price target is $21.33, with a high forecast of $22.00, and a low forecast of $21.00.
Highest Price Target
$22.00
Average Price Target
$21.33
Lowest Price Target
$21.00

SBRA SharesGrow Score Overview

56/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 41/100
Valuation — P/E, PEG, Forward PEG
GROWTH 83/100
Financials — average growth
PAST 75/100
strong — trend
HEALTH 17/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 55/100
Gross margin is + market cap
FUTURE 34/100
Analyst outlook — as buy
INCOME 85/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SBRA

~
VALUE Partial
41/100
SBRA trades at a trailing Price-to-Earnings (P/E) of 32.4 (S&P 500 average ~25). Forward PEG 2.7 — overvalued. Analyst consensus target is $21, implying +3.2% from the current price $20. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
83/100
SBRA: +7.5%/yr revenue is, +320.6%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
~
PAST Partial
75/100
SBRA: 3 / 4 years profitable. mixed. Score = 3 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Fail
17/100
Balance sheet SBRA: Debt-to-Equity (D/E) ratio 0.9 (moderate), Current ratio is 0.56 (tight liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
55/100
SBRA: Gross margin is 65% (-9 pp trend), $5B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 55/100. ≥ 70 = Pass.
View details →
FUTURE Fail
34/100
Analyst outlook: 11 / 29 analysts rate SBRA as buy (38%). Analyst consensus target is $21 (+3.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Pass
85/100
SBRA: Net profit margin is 20.1%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range15.75-21.07
Volume1.15M
Avg Volume (30D)2.67M
Market Cap$5.13B
Beta (1Y)0.65
Dividend Yield$1.2000
Share Statistics
EPS (TTM)0.64
Shares Outstanding$241.31M
IPO Date2002-04-02
Employees50
CEORichard K. Matros
Financial Highlights & Ratios
Revenue (TTM)$774.63M
Gross Profit$503.53M
EBITDA$456.83M
Net Income$155.61M
Operating Income$263.87M
Total Cash$71.54M
Total Debt$2.55B
Net Debt$2.48B
Total Assets$5.49B
Price / Earnings (P/E)31.8
Price / Sales (P/S)6.62
Analyst Forecast
1Y Price Target$21.00
Target High$22.00
Target Low$21.00
Upside+3.2%
Rating ConsensusHold
Analysts Covering29
Buy 38% Hold 55% Sell 7%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS78573L1061

Price Chart

SBRA
Sabra Health Care REIT, Inc.  ·  NASDAQ Global Select
Real Estate • REIT - Healthcare Facilities
15.75 52WK RANGE 21.07
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message